Wayne Bowler

Corporate Officer/Principal bei KYOWA KIRIN CO. LTD.

Health Technology

Profil

Wayne Bowler has held positions as a Business Development Director at Kyowa Kirin International Plc and as a Group Head-Business Development at Kyowa Kirin Co., Ltd.

Aktive Positionen von Wayne Bowler

Unternehmen	Position	Beginn
KYOWA KIRIN CO. LTD.	Corporate Officer/Principal	-
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Corporate Officer/Principal	-

Alle aktiven Positionen von Wayne Bowler

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Wayne Bowler im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
KYOWA KIRIN CO. LTD.	Health Technology

Private Unternehmen	1
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Health Technology